Our data suggest that 36-077 promotes the efficacy of 5-FU treatment in killing colon cancer cells by modulating the GSK-3β/Wnt/β-catenin signaling, further emphasizing the translational potential of this inhibitor for improving colon cancer therapy. This evidence concerns the gene GSK3B and colonic neoplasm.